Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling

A significant proportion of estrogen receptor‐positive (ER+) breast cancer (BC) initially responds to endocrine therapy but eventually evolves into therapy‐resistant BC. Transcription factor AP‐2 gamma (TFAP2C) is a known regulator of ER activity, and high expression of TFAP2C is associated with a d...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Junhao Liu, Zexuan Liu, Mengxing Li, Weiwei Tang, Uday P. Pratap, Yiliao Luo, Kristin A. Altwegg, Xiaonan Li, Yi Zou, Hong Zhu, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Ratna K. Vadlamudi
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2021-04-01
Schriftenreihe:	Molecular Oncology
Schlagworte:	breast cancer coactivator PELP1 TFAP2C therapy resistance
Online-Zugang:	https://doi.org/10.1002/1878-0261.12871
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!